Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Steiner Biotechnology LLC
483
•Steiner Biotechnology LLC•November 8, 2022

Steiner Biotechnology LLC – FDA 483, Nov 8, 2022

Record Details

An FDA inspection of Steiner Biotechnology, LLC, a medical device manufacturer, was conducted from November 3 to November 8, 2022. The inspection revealed multiple significant deficiencies in the company's quality management system, indicating non-compliance with the Federal Food, Drug, and Cosmetic Act concerning medical device regulations.

Key violations included a lack of established and documented procedures for design control, specifically regarding validation and verification for their OsseoConduct bone grafting material. The firm's risk analysis for OsseoConduct was found inadequate, failing to identify foreseeable hazards. Critical sterilization processes for products like Oral Bond Dental Adhesive, Socket Graft, and OsseoConduct were not validated. There were also failures to adequately evaluate and monitor suppliers for critical materials, establish comprehensive device history records with acceptance criteria, and ensure accurate labeling. Equipment calibration, particularly for the OsseoConduct sterilization unit, was not routinely performed. Environmental controls in cleanrooms were insufficient, with concerns about potential particulate contamination and inadequate personnel gowning procedures. The company had not conducted required quality audits nor adequately evaluated product complaints for Medical Device Report (MDR) reportability. Several of these issues were repeat observations from a prior inspection, highlighting persistent systemic problems.

Steiner Biotechnology, LLC is required to implement thorough corrective actions to address these fundamental quality system failures and achieve full regulatory compliance.

Company
Steiner Biotechnology LLC
Inspection date
November 8, 2022
Product type
devices
Office
Dallas District Office
People
  • Janet Pulver (Investigator)
  • Terri E. Gibson
View Company Profile

ID · b2a7640e-f1ba-48e6-8992-69cbfdbe32ad

Other documents for Steiner Biotechnology LLC
  • 483 - 2025-02-14February 14, 2025
  • 483 - 2024-02-01February 1, 2024
  • 483 - 2019-06-28June 28, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Steiner Biotechnology LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.